Pfizer Registry of Outcomes in Growth Hormone RESearch (PROGRES) 2.0: A multi-country non-interventional, observational, prospective cohort study among participants treated with human growth hormone (hGH) treatments Genotropin (somatropin) and Ngenla (somatrogon) under routine clinical care.

Study type

• Study topic:
  Human medicinal product
• Study type:
  Non-interventional study

Non-interventional study

• Non-interventional study design:
  Cohort

Study drug and medical condition

• Name of medicine:
  GENOTROPIN

  NGENLA
• Study drug International non-proprietary name (INN) or common name:
  SOMATROPIN

  SOMATROGON
• Anatomical Therapeutic Chemical (ATC) code:
  (H01AC08) somatrogon

  somatrogon